- Product Information
- About CIRD
- Client Support Coming Soon
- Product Information
- About CIRD
- Client Support
Nobivac®: Respira Bb
The UK's FIRST and ONLY injectable canine Bordetella vaccine
Learn more
INNOVATION ENABLING FLEXIBILITY
Nobivac® Respira Bb brings further innovation and flexibility to your canine infectious respiratory disease (CIRD) vaccination offering, empowering you to select the optimal approach for your patients, ensuring that all dogs who would benefit from protection can receive it.
Learn moreProtection Against Canine Infectious Respiratory Disease (CIRD)
CIRD is a common infectious disease of ‘social dogs’, with a wide range of pathogens implicated. Bordetella bronchiseptica is an important pathogen within this complex syndrome, but many pet dogs in the UK are currently unprotected against Bordetella bronchiseptica, whilst being regularly vaccinated against the core diseases.
Learn more
Bordetella bronchiseptica and Canine parainfluenza vaccination
Nobivac® Respira Bb1
| Contains: | Fimbrial antigen (unique subunit) of Bordetella bronchiseptica |
| Administration: | Subcutaneous injection |
| Primary Course: | Two doses |
| First booster: | 7 months (if missed, booster can be administered within 12 months of primary vaccination) |
| Subsequent booster: | Once a year |
| Pack Sizes: | 10 dose multi-dose vial |
Nobivac® Pi2
| Contains: | Canine parainfluenza |
| Administration: | Subcutaneous |
| Subcutaneous Booster: | Once a year (when Nobivac DHPPi is not administered) |
| Pack Sizes: | 10 and 50 dose packs |
Nobivac® KC3
| Contains: | Canine parainfluenza and Bordetella bronchiseptica |
| Administration: | Intranasal |
| Primary Course: | One dose |
| Booster: | Once a year |
| Pack Sizes: | 5 and 25 dose packs |
CIRD Webinar Coming Soon
Join Jenny Stavisky MRCVS BVM&S PhD PGCHE FHEA, Clinical Assistant Professor in Shelter Medicine and MSD Animal Health’s Michelle Townley BVM&S GP Cert (Fel P) MRCVS in discussion around why vaccination against CIRD is so important and how it has just become easier.
References:
- Nobivac® Respira Bb. Summary of Product Characteristics.
- Nobivac® Pi. Summary of Product Characteristics.
- Nobivac® KC. Summary of Product Characteristics.
Nobivac® Pi is a live attenuated vaccine containing canine parainfluenza virus. POM-V
Nobivac® Respira Bb is an inactivated subunit vaccine containing the fimbrial antigen of Bordetella bronchiseptica. POM-V
Nobivac® KC is an intranasal vaccine containing live attenuated strains of Bordetella Bronchiseptica and canine parainfluenza virus. POM-V
Further information is available from the SPC, Datasheet or package leaflet.
MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.
Advice should be sought from the medicine prescriber.
Use medicines responsibly.